0001651308-22-000177.txt : 20220922 0001651308-22-000177.hdr.sgml : 20220922 20220922173408 ACCESSION NUMBER: 0001651308-22-000177 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220920 FILED AS OF DATE: 20220922 DATE AS OF CHANGE: 20220922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OYLER JOHN CENTRAL INDEX KEY: 0001042047 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37686 FILM NUMBER: 221260188 MAIL ADDRESS: STREET 1: C/O GENTA INC STREET 2: 3550 GENERAL ATOMICS CT BLDG 9 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BeiGene, Ltd. CENTRAL INDEX KEY: 0001651308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981209416 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN) STREET 2: 94 SOLARIS AVENUE, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1108 BUSINESS PHONE: 13459494123 MAIL ADDRESS: STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN) STREET 2: 94 SOLARIS AVENUE, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1108 4 1 wf-form4_166388243470166.xml FORM 4 X0306 4 2022-09-20 0 0001651308 BeiGene, Ltd. BGNE 0001042047 OYLER JOHN C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN E9 KY1-1108 CAYMAN ISLANDS 1 1 0 0 Chief Executive Officer Ordinary Shares 2070913 D Ordinary Shares 545597 I See Footnote Ordinary Shares 7727927 I See Footnote Ordinary Shares 29114115 I See Footnote Ordinary Shares 9675000 I See Footnote Ordinary Shares 102188 I See Footnote American Depositary Shares 2022-09-20 4 S 0 9749 153.3184 D 5511 I See Footnote American Depositary Shares 2022-09-20 4 S 0 5411 153.8057 D 100 I See Footnote American Depositary Shares 2022-09-20 4 S 0 100 154.77 D 0 I See Footnote American Depositary Shares 2022-09-20 4 S 0 9748 153.3184 D 5512 I See Footnote American Depositary Shares 2022-09-20 4 S 0 5412 153.8057 D 100 I See Footnote American Depositary Shares 2022-09-20 4 S 0 100 154.77 D 0 I See Footnote American Depositary Shares 2022-09-21 4 S 0 2000 148.251 D 7740 I See Footnote American Depositary Shares 2022-09-21 4 S 0 2639 149.2122 D 5101 I See Footnote American Depositary Shares 2022-09-21 4 S 0 2435 150.3532 D 2666 I See Footnote American Depositary Shares 2022-09-21 4 S 0 1716 151.163 D 950 I See Footnote American Depositary Shares 2022-09-21 4 S 0 500 152.349 D 450 I See Footnote American Depositary Shares 2022-09-21 4 S 0 450 153.1178 D 0 I See Footnote American Depositary Shares 2022-09-21 4 S 0 2000 148.2512 D 7740 I See Footnote American Depositary Shares 2022-09-21 4 S 0 2638 149.2121 D 5102 I See Footnote American Depositary Shares 2022-09-21 4 S 0 2436 150.3532 D 2666 I See Footnote American Depositary Shares 2022-09-21 4 S 0 1716 151.1633 D 950 I See Footnote American Depositary Shares 2022-09-21 4 S 0 500 152.349 D 450 I See Footnote American Depositary Shares 2022-09-21 4 S 0 450 153.1178 D 0 I See Footnote These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership. These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account. These securities are held by The John Oyler Legacy Trust, of which the Reporting Person's father is a trustee, for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership. Each American Depositary Share represents 13 Ordinary Shares. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.56 to $153.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.56 to $154.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.69 to $154.85, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.81 to $148.72, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.81 to $149.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.81 to $150.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.81 to $151.63, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.84 to $152.82, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.885 to $153.40, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. /s/ Qing Nian, as Attorney-in-Fact 2022-09-22